BEYANG Therapeutics Co., Ltd. is an innovative biopharmaceutical company that employs its proprietary ExCEED platforms to accelerate the process of new drug discovery and development in disease areas of significant unmet medical needs.
ExCEED Platform
- Chemistry
- Bioassay
- Cloud
- SBDD
- AI
- PBPK
- Toxicity
- Formulation
- Efficacy
- PD/biomarker
Pipeline
| Area | Project | Indication | Administration | Region | Discovery | PCC | IND | Phase1/2 |
|---|
| Ophthalmology | BT01001 | Severe Non-Proliferative Diabetic Retinopathy (sNPDR) | Eye Drop | Global |
|
| Ophthalmology | BT01006 | Intermediate AMD | Eye Drop | Global |
|
| Oncology | BY002 | AML/ALL (KMT2A-r or NPM1) | Oral | Global |
|
| Metabolism | BY003 | Type 1&2 Diabete (β-cell Regeneration) | Oral | Global |
|
Join us
